About The Cover
The cover for issue 34 of Oncotarget features Figure 1, "BRAF inhibitor-induced changes in cell viability," by Pickles, et al.
Table of Contents
Research Papers
Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer
| Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27681 Oliver J. Pickles, Aneta Drozd, Louise Tee, Andrew D. Beggs, and Gary W. Middleton |
| 3188-3197 |
| Abstract | PDF | Full Text | How to cite | Press Release |
Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers
| Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers |
|
https://doi.org/10.18632/oncotarget.27682 Takeyuki Suzuki, Tetsutaro Suzuki, Yukino Yoshimura, Mitsunori Yahata, Poh Yin Yew, Tetsuya Nakamura, Yusuke Nakamura, Jae-Hyun Park, and Ryota Matsuo |
| 3198-3207 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL)
| The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL) |
|
https://doi.org/10.18632/oncotarget.27683 Stefan Nagel, Claudia Pommerenke, Roderick A.F. MacLeod, Corinna Meyer, Maren Kaufmann, and Hans G. Drexler |
| 3208-3226 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Differentially expressed full-length, fusion and novel isoforms transcripts-based signature of well-differentiated keratinized oral squamous cell carcinoma
| Differentially expressed full-length, fusion and novel isoforms transcripts-based signature of well-differentiated keratinized oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27693 Neetu Singh, Dinesh Kumar Sahu, Ratnesh Kumar Tripathi, Archana Mishra, Hari Shyam, Pratap Shankar, Mayank Jain, Nawazish Alam, Anil Kumar, Abhishek Mishra, Rebecca Chowdhry, Anjana Singh, Sameer Gupta, Divya Mehrotra, Preeti Agarwal, Madhu Mati Goel, Arun Chaturvedi, Satya Prakash Agarwal, Manish Bajpai, Devendra Kumar Gupta, Madan Lal Brahma Bhatt, and Ravi Kant |
| 3227-3243 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1
| Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1 |
|
https://doi.org/10.18632/oncotarget.27696 Gajanan Sathe, Irene A. George, Barnali Deb, Ankit P. Jain, Krishna Patel, Brusabhanu Nayak, Subhradip Karmakar, Amlesh Seth, Akhilesh Pandey, and Prashant Kumar |
| 3244-3255 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Case Reports
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy
| A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy |
|
https://doi.org/10.18632/oncotarget.27701 Matteo Torresetti, Donatella Brancorsini, Francesca Morgese, Valeria Cognigni, Alessandro Scalise, Rossana Berardi, and Giovanni Di Benedetto |
| 3256-3262 |
| Abstract | PDF | Full Text | How to cite |
Corrections
Correction: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression
| Correction: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression |
|
https://doi.org/10.18632/oncotarget.27729 Chang Li, Lei Song, Zhuo Zhang, Xiao-Xue Bai, Ming-Fu Cui, and Lian-Jun Ma |
| 3263-3264 |
| Correction | PDF | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals